nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia
|
Sevy, Serge |
|
2010 |
120 |
1-3 |
p. 101-107 7 p. |
artikel |
2 |
Association of NPAS3 exonic variation with schizophrenia
|
Macintyre, Georgina |
|
2010 |
120 |
1-3 |
p. 143-149 7 p. |
artikel |
3 |
Asymmetry loss is local rather than global in adolescent onset schizophrenia
|
Clark, Gina M. |
|
2010 |
120 |
1-3 |
p. 84-86 3 p. |
artikel |
4 |
Atypical antipsychotic drugs upregulate synapsin II in the prefrontal cortex of post-mortem samples obtained from patients with schizophrenia
|
Guest, Kelly A. |
|
2010 |
120 |
1-3 |
p. 229-231 3 p. |
artikel |
5 |
Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: The UCLA family study
|
Fogelson, D.L. |
|
2010 |
120 |
1-3 |
p. 113-120 8 p. |
artikel |
6 |
Cannabis use disorders in schizophrenia: Effects on cognition and symptoms
|
DeRosse, Pamela |
|
2010 |
120 |
1-3 |
p. 95-100 6 p. |
artikel |
7 |
Cognitive differences between men and women: A comparison of patients with schizophrenia and healthy volunteers
|
Longenecker, Julia |
|
2010 |
120 |
1-3 |
p. 234-235 2 p. |
artikel |
8 |
Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis
|
Patel, Anita |
|
2010 |
120 |
1-3 |
p. 217-224 8 p. |
artikel |
9 |
Conceptual combination and language in schizophrenia
|
Elvevåg, B. |
|
2010 |
120 |
1-3 |
p. 238-239 2 p. |
artikel |
10 |
Consanguinity and increased risk for schizophrenia in Egypt
|
Mansour, Hader |
|
2010 |
120 |
1-3 |
p. 108-112 5 p. |
artikel |
11 |
Convergent Evidence Shows a Positive Association of Interleukin-1 Gene Complex Locus with Susceptibility to Schizophrenia in the Caucasian population
|
Xu, Mingqing |
|
2010 |
120 |
1-3 |
p. 131-142 12 p. |
artikel |
12 |
Discrepant nocturnal melatonin levels in monozygotic twins discordant for schizophrenia and its impact on sleep
|
P., Afonso |
|
2010 |
120 |
1-3 |
p. 227-228 2 p. |
artikel |
13 |
Editorial Board
|
|
|
2010 |
120 |
1-3 |
p. IFC- 1 p. |
artikel |
14 |
Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia
|
Docherty, J.P. |
|
2010 |
120 |
1-3 |
p. 199-203 5 p. |
artikel |
15 |
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: A randomized five month study
|
Smith, Robert C. |
|
2010 |
120 |
1-3 |
p. 204-209 6 p. |
artikel |
16 |
Elevated PICK1 mRNA in schizophrenia increased SRR mRNA in suicide
|
Sarras, Haya |
|
2010 |
120 |
1-3 |
p. 236-237 2 p. |
artikel |
17 |
Functional magnetic resonance imaging of choice reaction time in chronic schizophrenia and first-degree relatives
|
McAllindon, David P. |
|
2010 |
120 |
1-3 |
p. 232-233 2 p. |
artikel |
18 |
Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia
|
Kerns, David |
|
2010 |
120 |
1-3 |
p. 150-158 9 p. |
artikel |
19 |
Gray-matter abnormalities in deficit schizophrenia
|
Cascella, Nicola G. |
|
2010 |
120 |
1-3 |
p. 63-70 8 p. |
artikel |
20 |
Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder
|
Slonimsky, Alexandra |
|
2010 |
120 |
1-3 |
p. 159-166 8 p. |
artikel |
21 |
One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia
|
Eack, Shaun M. |
|
2010 |
120 |
1-3 |
p. 210-216 7 p. |
artikel |
22 |
Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort
|
Glaser, B. |
|
2010 |
120 |
1-3 |
p. 177-183 7 p. |
artikel |
23 |
Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: An empirical question
|
Yang, Lawrence H. |
|
2010 |
120 |
1-3 |
p. 42-48 7 p. |
artikel |
24 |
Probably at-risk, but certainly ill — Advocating the introduction of a psychosis spectrum disorder in DSM-V
|
Ruhrmann, Stephan |
|
2010 |
120 |
1-3 |
p. 23-37 15 p. |
artikel |
25 |
Progressive lateral ventricular enlargement in schizophrenia: A meta-analysis of longitudinal MRI studies
|
Kempton, Matthew J. |
|
2010 |
120 |
1-3 |
p. 54-62 9 p. |
artikel |
26 |
Risk syndromes, clinical staging and DSM V: New diagnostic infrastructure for early intervention in psychiatry
|
McGorry, Patrick D. |
|
2010 |
120 |
1-3 |
p. 49-53 5 p. |
artikel |
27 |
Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population
|
Breetvelt, Elemi J. |
|
2010 |
120 |
1-3 |
p. 184-190 7 p. |
artikel |
28 |
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia
|
van Veelen, Nicoletta M.J. |
|
2010 |
120 |
1-3 |
p. 191-198 8 p. |
artikel |
29 |
Should a “Risk Syndrome for Psychosis” be included in the DSMV?
|
Yung, Alison R. |
|
2010 |
120 |
1-3 |
p. 7-15 9 p. |
artikel |
30 |
Subcortical alignment precision in patients with schizophrenia
|
Anticevic, Alan |
|
2010 |
120 |
1-3 |
p. 76-83 8 p. |
artikel |
31 |
Subjective rating of working memory is associated with frontal lobe volume in schizophrenia
|
Garlinghouse, Matthew A. |
|
2010 |
120 |
1-3 |
p. 71-75 5 p. |
artikel |
32 |
Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American Ancestry
|
Jiménez-Castro, Lorena |
|
2010 |
120 |
1-3 |
p. 87-94 8 p. |
artikel |
33 |
The impact of a family history of psychosis on age-at-onset and positive and negative symptoms of schizophrenia: A meta-analysis
|
Esterberg, Michelle L. |
|
2010 |
120 |
1-3 |
p. 121-130 10 p. |
artikel |
34 |
The importance of a good night's sleep: An open-label trial of the sodium salt of γ-hydroxybutyric acid in insomnia associated with schizophrenia
|
Kantrowitz, Joshua T. |
|
2010 |
120 |
1-3 |
p. 225-226 2 p. |
artikel |
35 |
The interaction of working memory and emotion in persons clinically at risk for psychosis: An fMRI pilot study
|
Pauly, Katharina |
|
2010 |
120 |
1-3 |
p. 167-176 10 p. |
artikel |
36 |
The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk–benefit analysis
|
Corcoran, Cheryl M. |
|
2010 |
120 |
1-3 |
p. 16-22 7 p. |
artikel |
37 |
The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid?
|
Yung, Alison R. |
|
2010 |
120 |
1-3 |
p. 1-6 6 p. |
artikel |
38 |
The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population
|
Wang, Yu |
|
2010 |
120 |
1-3 |
p. 240-242 3 p. |
artikel |
39 |
Valuing prodromal psychosis: What do we get and what is the price?
|
Drake, Richard J. |
|
2010 |
120 |
1-3 |
p. 38-41 4 p. |
artikel |